XIFAXAN cpr pell 550 mg 56 pce

7680632160025 CH-63216 A07AA11 08.01.9.

Reimbursement limitations:

XIFAXAN

Indiqué pour la diminution des récidives d’épisodes d’encéphalopathies hépatiques manifestes chez les patients >= 18 …

XIFAXAN cpr pell 550 mg 56 pce
XIFAXAN cpr pell 550 mg 56 pce
XIFAXAN cpr pell 550 mg 56 pce
1 / 3
google

Details

Product number
6321601
CPT
-
Packaging group
56
Unit
Tablette(n)
Composition
rifaximinum 550 mg, carboxymethylamylum natricum A, glyceroli distearas, silica colloidalis anhydrica, talcum, cellulosum microcristallinum, Überzug: hypromellosum, dinatrii edetas, propylenglycolum, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 1.74 mg.

Articles (1)

Xifaxan 550 mg, Filmtabletten
Filmtabletten
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/06/2023
Patient information leaflet
Français
02/06/2023
Patient information leaflet
Italien
02/06/2023
Professional SmPC
Allemand
02/06/2023
Professional SmPC
Français
02/06/2023
Professional SmPC
Italien
02/06/2023

Detailed composition

Substance Quantity Type Category
(N/A)
550.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
1.74 MG Substance HBESI

Reimbursement information

Public price
CHF 352.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2015

Authorization holder

Alfasigma Schweiz AG

4800 Zofingen

Authorization information

Swissmedic authorization number
63216
Drug name
Xifaxan 550 mg, Filmtabletten
Galenic form
FILM
ATC Code
A07AA11
Authorization status
Z
Dispensation category
B
First authorization
19/03/2015
Authorization expiration date
31/12/9999
IT number
08.01.9.
Domain
Human medicine
Field of application
Zur Verminderung des Wiederauftretens von Episoden einer manifesten hepatischen Enzephalopathie bei Patienten mit hepatischer Zirrhose

Packaging details

Description (FR)
XIFAXAN cpr pell 550 mg 56 pce
Description (DE)
XIFAXAN Filmtabl 550 mg 56 Stk
Market launch
19/03/2015
Narcotic (BTM)
No

Other packaging sizes